Orasure Technologies Inc revenue
Orasure Technologies Inc's revenue was $115m in fiscal 2025, down 38.1% on the year before. Since fiscal 2009 ($77.0m) it has grown at a compound 2.5% a year. Over the last twelve months it was $112m.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77 | 75 | 82 | 88 | 99 | 106 | 120 | 128 | 167 | 182 | 155 | 172 | 234 | 387 | 405 | 186 | 115 | 112 |
| Growth on the year before | — | −2.6% | +9.2% | +7.3% | +12.7% | +7.6% | +12.5% | +7.1% | +30.3% | +8.8% | −14.9% | +11.1% | +36.1% | +65.8% | +4.6% | −54.2% | −38.1% | — |
| Gross profit | 47 | 47 | 52 | 56 | 59 | 67 | 80 | 88 | 99 | 114 | 95 | 102 | 118 | 148 | 172 | 79 | 48 | 48 |
| Gross margin | 61.2% | 63.1% | 63.2% | 63.3% | 59.2% | 62.6% | 67.1% | 68.7% | 59.2% | 62.5% | 61.2% | 59.3% | 50.3% | 38.3% | 42.3% | 42.7% | 41.9% | 42.6% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Product and Services | $109M | 94.8% | ▼ 40.9% |
| Other Revenues | $6M | 5.2% | ▲ 390.6% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $78.3M | 68.0% | ▼ 43.8% |
| Africa | $24M | 20.9% | ▼ 26.7% |
| Europe | $7.4M | 6.4% | ▼ 12.2% |
| Other Foreign Countries | $5.4M | 4.7% | ▼ 2.1% |
From Orasure Technologies Inc's 10-K filed March 9, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Orasure Technologies Inc | $112m | -18.9% | -38.4% |
| Mimedx Group, Inc. | $304m | -22.8% | -0.6% |
| Organogenesis Holdings Inc. | $457m | 6.5% | 0.0% |
| UFP Technologies Inc | $632m | 7.3% | 17.8% |
| Embecta Corp. | $1.02bn | -7.6% | -2.9% |
| Nexgel, Inc. | $12.1m | 3.4% | 61.2% |
Compare with peers
- Mimedx Group, Inc. revenue
- Organogenesis Holdings Inc. revenue
- UFP Technologies Inc revenue
- Embecta Corp. revenue
- Nexgel, Inc. revenue
Head to head: MDXG vs OSURORGO vs OSUROSUR vs UFPTNXGL vs OSUR
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies